Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pramlintide”

58 trials

Showing 20 of 58 results

Testing effectiveness (Phase 2)Study completedNCT00444561
What this trial is testing

Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 184
Large-scale testing (Phase 3)Study completedNCT00107107
What this trial is testing

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
AstraZeneca 190
Post-approval studies (Phase 4)Study completedNCT00950677
What this trial is testing

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Baylor College of Medicine 16
Not applicableStudy completedNCT00489645
What this trial is testing

Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide

Who this might be right for
Type 1 Diabetes
Ludwig-Maximilians - University of Munich 27
Testing effectiveness (Phase 2)Study completedNCT00042471
What this trial is testing

Evaluation of the Bioavailability of Pramlintide

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
AstraZeneca 75
Post-approval studies (Phase 4)WithdrawnNCT00505882
What this trial is testing

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT03916640
What this trial is testing

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Adocia 24
Testing effectiveness (Phase 2)Study completedNCT00042601
What this trial is testing

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
AstraZeneca 51
Post-approval studies (Phase 4)Study completedNCT01841359
What this trial is testing

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

Who this might be right for
HypoglycemiaEvidence of Previous Gastric Surgery
Joslin Diabetes Center 22
Not applicableStudy completedNCT01839370
What this trial is testing

Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
University of Virginia 9
Not applicableEnded earlyNCT03547427
What this trial is testing

Glucagon Counterregulation in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Virginia 13
Large-scale testing (Phase 3)Looking for participantsNCT06046417
What this trial is testing

A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes

Who this might be right for
type1diabetesDiabetes Mellitus, Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Testing effectiveness (Phase 2)Study completedNCT02814123
What this trial is testing

Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
McGill University 28
Testing effectiveness (Phase 2)Study completedNCT00392925
What this trial is testing

Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 177
Early research (Phase 1)Study completedNCT01269008
What this trial is testing

Closed Loop System With Pramlintide Versus Exenatide

Who this might be right for
Type 1 Diabetes
Albert Einstein College of Medicine 13
Testing effectiveness (Phase 2)Study completedNCT03800875
What this trial is testing

Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

Who this might be right for
Diabetes Mellitus, Type 1
McGill University 24
Testing effectiveness (Phase 2)Study completedNCT00313183
What this trial is testing

Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 12
Post-approval studies (Phase 4)Study completedNCT00467649
What this trial is testing

Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 112
Testing effectiveness (Phase 2)Ended earlyNCT01235741
What this trial is testing

Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

Who this might be right for
Obesity
AstraZeneca 213
Post-approval studies (Phase 4)Study completedNCT00240253
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation